AstraZeneca Kovid-19 Vaccine (Photo Credits: Instagram)
Geneva, 8 April: There may be a correlation between the rare occurrence of blood clots with AstraZeneca Covid-19 Vaccine and reduced platelets, but this has not been confirmed. The World Health Organization (WHO) has said this. Earlier, the European Medicine Agency (EMA) confirmed that cases of blood clotting and reduced platelets are associated with the introduction of the AstraZeneca covid-19 vaccine dose, but should still be considered as a very rare effect. The WHO’s Global Advisory Committee on Vaccine Safety (GACVS) issued an interim statement on Wednesday, saying that such incidents are very rare, as reported by Xinhua. Very few such cases have been reported among people receiving about 200 million AstraZeneca vaccines.
However, a special study is needed to fully understand this potential relationship and the GACVS has stated that it will continue to collect and review the data further. The GACVS also stated that rare adverse events that occur after vaccination should be evaluated by data on how effective the vaccine has been in reducing Kovid-19 infection and deaths. Also read: 1,26,789 new cases of COVID19, 59,258 discharges and 685 deaths in the last 24 hours in India: Ministry of Health
Because according to WHO data, till Wednesday at least 26 lakh people have died from Kovid-19 worldwide. Let us know that many European countries have stopped or suspended the use of AstraZeneca vaccine in view of the risk of adverse events.